A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Metronidazole Vaginal Gel 1.3% in Adolescent Female Subjects With Bacterial Vaginosis

Trial Profile

A Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Metronidazole Vaginal Gel 1.3% in Adolescent Female Subjects With Bacterial Vaginosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Oct 2017

At a glance

  • Drugs Metronidazole (Primary)
  • Indications Bacterial vaginosis
  • Focus Adverse reactions
  • Sponsors Actavis; Allergan
  • Most Recent Events

    • 17 May 2017 Status changed from active, no longer recruiting to completed.
    • 31 Oct 2016 Planned End Date changed from 1 Jun 2017 to 1 Nov 2016.
    • 31 Oct 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Oct 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top